Prothena Corporation (PRTA)
Prothena Statistics
Share Statistics
Prothena has 53.83M shares outstanding. The number of shares has increased by 0.1% in one year.
| Shares Outstanding | 53.83M |
| Shares Change (YoY) | 0.1% |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | 99.49% |
| Shares Floating | 42.5M |
| Failed to Deliver (FTD) Shares | 70 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 9.35M, so 17.38% of the outstanding shares have been sold short.
| Short Interest | 9.35M |
| Short % of Shares Out | 17.38% |
| Short % of Float | 20.87% |
| Short Ratio (days to cover) | 12.45 |
Valuation Ratios
The PE ratio is -6.09 and the forward PE ratio is -3.85. Prothena's PEG ratio is 0.34.
| PE Ratio | -6.09 |
| Forward PE | -3.85 |
| PS Ratio | 5.51 |
| Forward PS | 0.7 |
| PB Ratio | 1.53 |
| P/FCF Ratio | -4.95 |
| PEG Ratio | 0.34 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Prothena.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.01, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.01 |
| Quick Ratio | 10.01 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | -0.07 |
| Debt / FCF | -0.07 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $829.18K |
| Profits Per Employee | $-750.37K |
| Employee Count | 163 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.62M |
| Effective Tax Rate | 5.13% |
Stock Price Statistics
The stock price has increased by -54.91% in the last 52 weeks. The beta is 0.07, so Prothena's price volatility has been higher than the market average.
| Beta | 0.07 |
| 52-Week Price Change | -54.91% |
| 50-Day Moving Average | 13.73 |
| 200-Day Moving Average | 17.08 |
| Relative Strength Index (RSI) | 28.02 |
| Average Volume (20 Days) | 431.14K |
Income Statement
In the last 12 months, Prothena had revenue of 135.16M and earned -122.31M in profits. Earnings per share was -2.27.
| Revenue | 135.16M |
| Gross Profit | 135.16M |
| Operating Income | -154.56M |
| Net Income | -122.31M |
| EBITDA | -154.56M |
| EBIT | -154.56M |
| Earnings Per Share (EPS) | -2.27 |
Balance Sheet
The company has 471.39M in cash and 10.84M in debt, giving a net cash position of 460.55M.
| Cash & Cash Equivalents | 471.39M |
| Total Debt | 10.84M |
| Net Cash | 460.55M |
| Retained Earnings | -1.1B |
| Total Assets | 547.11M |
| Working Capital | 436.91M |
Cash Flow
In the last 12 months, operating cash flow was -150.05M and capital expenditures -298K, giving a free cash flow of -150.35M.
| Operating Cash Flow | -150.05M |
| Capital Expenditures | -298K |
| Free Cash Flow | -150.35M |
| FCF Per Share | -2.8 |
Margins
Gross margin is 100%, with operating and profit margins of -114.36% and -90.49%.
| Gross Margin | 100% |
| Operating Margin | -114.36% |
| Pretax Margin | -95.39% |
| Profit Margin | -90.49% |
| EBITDA Margin | -114.36% |
| EBIT Margin | -114.36% |
| FCF Margin | -111.24% |
Dividends & Yields
PRTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PRTA is $55, which is 434.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $55 |
| Price Target Difference | 434.5% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Scores
| Altman Z-Score | 3.07 |
| Piotroski F-Score | 2 |